Skip to main content

Prédispositions génétiques aux cancers de l’ovaire

  • Chapter
Les cancers ovariens

Part of the book series: Abord clinique ((ONCOLPRAT))

  • 337 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Trétarre B (2003) Ovaire. In Réseau français des registres de cancers, Hôpitaux de Lyon, Institut national de la santé et de la recherche médicale, Institut de veille sanitaire (eds) Evolution de l’incidence et de la mortalité par cancer en France de 1978 à 2000, p. 119–24

    Google Scholar 

  2. Auranen A, Pukkala E, Makinen J et al. (1996) Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer 74: 280–4

    CAS  PubMed  Google Scholar 

  3. Stettner AR, Hartenbach EM, Schink JC et al. (1999) Familial ovarian germ cell cancer: report and review. Am J Med Genet 84: 43–6

    Article  CAS  PubMed  Google Scholar 

  4. Giardiello FM, Brensinger JD, Tersmette AC et al. (2000) Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119: 1447–53

    Article  CAS  PubMed  Google Scholar 

  5. Longy M, Toulouse C, Mage P et al. (1996) Familial cluster of ovarian small cell carcinoma: a new mendelian entity? J Med Genet 33: 333–5

    CAS  PubMed  Google Scholar 

  6. Stratakis CA, Papageorgiou T, Premkumar A et al. (2000) Ovarian lesions in Carney complex: clinical genetics and possible predisposition to malignancy. J Clin Endocrinol Metab 85: 4359–66

    CAS  PubMed  Google Scholar 

  7. Miki Y, Swensen J, Shattuck-Eidens D et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71

    CAS  PubMed  Google Scholar 

  8. Wooster R, Bignell G, Lancaster J et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–92

    Article  CAS  PubMed  Google Scholar 

  9. Ford D, Easton DF, Stratton M et al. (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62: 676–89

    Article  CAS  PubMed  Google Scholar 

  10. Narod S, Ford D, Devilee P et al. (1995) Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. Am J Hum Genet 57:957–8

    CAS  PubMed  Google Scholar 

  11. Antoniou AC, Pharoah PD, McMullan G et al. (2002) A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes. Br J Cancer 86: 76–83

    Article  CAS  PubMed  Google Scholar 

  12. Stratton JF, Gayther SA, Russell P et al. (1997) Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 336: 1125–30

    Article  CAS  PubMed  Google Scholar 

  13. Risch HA, McLaughlin JR, Cole DE et al. (2001) Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer. Am J Hum Genet 68: 700–10

    Article  CAS  PubMed  Google Scholar 

  14. Aziz S, Kuperstein G, Rosen B et al. (2001) A genetic epidemiological study of carcinoma of the fallopian tube. Gynecol Oncol 80: 341–5

    Article  CAS  PubMed  Google Scholar 

  15. Ford D, Easton DF, Bishop DT et al. (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692–5

    Article  CAS  PubMed  Google Scholar 

  16. Antoniou A, Pharoah PD, Narod S et al. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117–30

    Article  CAS  PubMed  Google Scholar 

  17. Narod SA (2002) Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev 2: 113–23

    Google Scholar 

  18. Boyd J, Sonoda Y, Federici MG et al. (2000) Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. Jama 283: 2260–5

    Article  CAS  PubMed  Google Scholar 

  19. Narod S, Tonin P, Lynch H et al. (1994) Histology of BRCA1-associated ovarian tumours. Lancet 343: 236

    Article  CAS  PubMed  Google Scholar 

  20. Werness BA, Ramus SJ, DiCioccio RA et al. (2004) Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Int J Gynecol Pathol 23: 29–34

    PubMed  Google Scholar 

  21. Lynch HT, Smyrk TC, Watson P et al. (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastro-enterology 104: 1535–49

    CAS  Google Scholar 

  22. Vasen HF, Mecklin JP, Khan PM et al. (1991) The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34: 424–5

    Article  CAS  PubMed  Google Scholar 

  23. Vasen HF, Watson P, Mecklin JP et al. (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116: 1453–6

    Article  CAS  PubMed  Google Scholar 

  24. Aaltonen LA, Peltomaki P, Leach FS et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812–6

    CAS  PubMed  Google Scholar 

  25. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260: 816–9

    CAS  PubMed  Google Scholar 

  26. Papadopoulos N, Lindblom A (1997) Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 10: 89–99

    Article  CAS  PubMed  Google Scholar 

  27. Liu B, Parsons R, Papadopoulos N et al. (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169–74

    CAS  PubMed  Google Scholar 

  28. Aarnio M, Mecklin JP, Aaltonen LA et al. (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64: 430–3

    CAS  PubMed  Google Scholar 

  29. Aarnio M, Sankila R, Pukkala E et al. (1999) Cancer risk in mutation carriers of DNAmismatch-repair genes. Int J Cancer 81: 214–8

    Article  CAS  PubMed  Google Scholar 

  30. Stratton JF, Thompson D, Bobrow L et al. (1999) The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. Am J Hum Genet 65: 1725–32

    Article  CAS  PubMed  Google Scholar 

  31. Salovaara R, Loukola A, Kristo P et al. (2000) Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18: 2193–200

    CAS  PubMed  Google Scholar 

  32. Peel DJ, Ziogas A, Fox EA et al. (2000) Characterization of hereditary nonpolyposis colorectal cancer families from a population-based series of cases. J Natl Cancer Inst 92: 1517–22

    Article  CAS  PubMed  Google Scholar 

  33. Stettner AR, Hartenbach EM, Schink JC et al. (1999) Familial ovarian germ cell cancer: report and review. Am J Med Genet 84: 43–6

    Article  CAS  PubMed  Google Scholar 

  34. Papageorgiou T, Stratakis CA (2002) Ovarian tumors associated with multiple endo-crine neoplasias and related syndromes (Carney complex, Peutz-Jeghers syndrome, von Hip-pel-Lindau disease, Cowden’s disease). Int J Gynecol Cancer 12: 337–47

    Article  CAS  PubMed  Google Scholar 

  35. Olschwang S, Boisson C, Thomas G (2001) Peutz-Jeghers families unlinked to STK11/ LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet 38: 356–60

    Article  CAS  PubMed  Google Scholar 

  36. Dickersin GR, Kline IW, Scully RE (1982) Small cell carcinoma of the ovary with hypercalcemia: a report of eleven cases. Cancer 49: 188–97

    CAS  PubMed  Google Scholar 

  37. Carney JA, Hruska LS, Beauchamp GD et al. (1986) Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Mayo Clin Proc 61: 165–72

    CAS  Google Scholar 

  38. Kirschner LS, Carney JA, Pack SD et al. (2000) Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 26: 89–92

    CAS  PubMed  Google Scholar 

  39. Eisinger F, Bressac B, Castaigne D et al. (2004) Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004). Bull Cancer 91: 219–37

    PubMed  Google Scholar 

  40. Olschwang S, Bonaiti C, Feingold J et al. (2004) Identification and management of HNPCC syndrome (hereditary non polyposis colon cancer), hereditary predisposition to colo-rectal and endometrial adenocarcinomas]. Bull Cancer 91: 303–15

    PubMed  Google Scholar 

  41. Rebbeck TR (2002) Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur J Cancer 38Suppl 6: S15–7

    CAS  PubMed  Google Scholar 

  42. Lynch HT, Watson P, Shaw TG et al. (1999) Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary non-polyposis colorectal carcinoma as a model. Cancer 86: 2457–63

    CAS  PubMed  Google Scholar 

  43. Petricoin EF, Ardekani AM, Hitt BA et al. (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572–7

    CAS  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France

About this chapter

Cite this chapter

Coupier, I., Delnatte, C., Lejeune-Dumoulin, S., This, P., Gauthier-Villars, M., Stoppa-Lyonnet, D. (2006). Prédispositions génétiques aux cancers de l’ovaire. In: Les cancers ovariens. Abord clinique. Springer, Paris. https://doi.org/10.1007/2-287-30921-7_2

Download citation

  • DOI: https://doi.org/10.1007/2-287-30921-7_2

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25168-9

  • Online ISBN: 978-2-287-30921-2

Publish with us

Policies and ethics